ICD-10 Specific code C77: Secondary and unspecified malignant neoplasm of lymph nodes

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English Secondary and unspecified malignant neoplasm of lymph nodes
Flag for French language  French Tumeur maligne des ganglions lymphatiques, secondaire et non prรฉcisรฉe

Hierarchical position

Level Code Title
1 II Neoplasms
2 C00-C97 Malignant neoplasms
3 C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
4 C77 Secondary and unspecified malignant neoplasm of lymph nodes

Contents

Code Title
C77.0 Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
C77.1 Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
C77.2 Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
C77.3 Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
C77.4 Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
C77.5 Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
C77.8 Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
C77.9 Secondary and unspecified malignant neoplasm: Lymph node, unspecified

Indicated medicines

Active Ingredient Description
Ifosfamide

Ifosfamide is an antineoplastic, a cytotoxic alkylating agent. It is a prodrug and shows no in vitro cytotoxic activity until activated by microsomal enzymes. The cytotoxic activity of ifosfamide (alkylation of the nucleophilic centres in the cells) is associated with the activated oxazaphosphorine ring hydroxylated at the C4 atom which interacts with DNA-DNA cross linking. This activity manifests itself by blocking the late S and early G2 phases of the cell cycle.